000			02159 a2200577 4500
005			20250517095324.0
264		0	_c20170502
008			201705s 0 0 eng d
022			_a1873-569X
024	7		_a10.1016/j.jdermsci.2016.03.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aFang, Fengjun
245	0	0	_aBone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling. _h[electronic resource]
260			_bJournal of dermatological science _cAug 2016
300			_a95-105 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aBone Marrow Cells _xcytology
650	0	4	_aCell Proliferation
650	0	4	_aCells, Cultured
650	0	4	_aCicatrix, Hypertrophic _xmetabolism
650	0	4	_aCollagen Type I _xmetabolism
650	0	4	_aConnective Tissue Growth Factor _xantagonists & inhibitors
650	0	4	_aCulture Media, Conditioned _xpharmacology
650	0	4	_aDecorin _xantagonists & inhibitors
650	0	4	_aExtracellular Matrix _xmetabolism
650	0	4	_aFemale
650	0	4	_aFibroblasts _xpathology
650	0	4	_aFibronectins _xantagonists & inhibitors
650	0	4	_aHumans
650	0	4	_aKeloid _xmetabolism
650	0	4	_aMale
650	0	4	_aMesenchymal Stem Cells _xdrug effects
650	0	4	_aMiddle Aged
650	0	4	_aParacrine Communication
650	0	4	_aPlasminogen Activator Inhibitor 1 _xmetabolism
650	0	4	_aReal-Time Polymerase Chain Reaction
650	0	4	_aSkin _xcytology
650	0	4	_aTransforming Growth Factor beta1 _xmetabolism
650	0	4	_aTransforming Growth Factor beta2 _xmetabolism
650	0	4	_aTransforming Growth Factor beta3 _xmetabolism
650	0	4	_aWound Healing _xphysiology
650	0	4	_aYoung Adult
700	1		_aHuang, Ru-Lin
700	1		_aZheng, Yongchao
700	1		_aLiu, Ming
700	1		_aHuo, Ran
773	0		_tJournal of dermatological science _gvol. 83 _gno. 2 _gp. 95-105
856	4	0	_uhttps://doi.org/10.1016/j.jdermsci.2016.03.003 _zAvailable from publisher's website
999			_c26047005 _d26047005